SF Research Institute

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, SF Research Institute sits in the top decile of US sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count).

16 total trials 8 currently recruiting 6 completed top decile by trial count

SF Research Institute: 16 sponsored US clinical trials, 8 recruiting.

SF Research Institute sponsors 16 registered US clinical trials on ClinicalTrials.gov, 8 of them currently recruiting, and 6 completed. The most-studied condition in this pipeline is Stress, with 2 trials.

Top-decile sponsor footprint

SF Research Institute ranks in the top decile of sponsors by registered trial count (#886 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

16 total, page 1 of 1

RECRUITING NA

Efficacy and Safety of Shatavari Root Extract in Women's Sexual Wellness

NCT07441083

RECRUITING NA

Effect of Ashwagandha Root Extract on Stress, Anxiety, and Sleep Quality in Adults Experiencing Minority Stress

NCT07441070

RECRUITING NA

An 8-Week Study Evaluating Gut and Digestive Health After Use of a Dietary Supplement System

NCT07421596

RECRUITING NA

A Study of a Dietary Supplement on Serum Biomarkers in Children

NCT07385144

RECRUITING NA

Effects of Sabroxy® Supplementation on Insulin Resistance and Cognitive Function in Adults With Mild Cognitive Impairment and Insulin Resistance

NCT07220694

RECRUITING NA

Effects of KSM-66 Ashwagandha® (300 mg) on Skin and Hair Health in Healthy Men and Women"

NCT07215689

RECRUITING NA

Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study

NCT06716554

RECRUITING NA

Efficacy and Safety of a Proprietary Blend of Ashwagandha Root Extract (Aqueous) in Adult Men and Women With High Stress and Anxiety: A Randomized, Double-blind, Three-arm, Parallel, Placebo-controlled Study

NCT06714942

NOT YET RECRUITING NA

Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women

NCT07441096

NOT YET RECRUITING NA

Shatavari Root Extract for Perimenopausal Symptoms

NCT07441109

COMPLETED NA

Ashwagandha Extract for Weight and Stress Management in Overweight and Obese Adults

NCT07215455

COMPLETED NA

Effect of Single Dose of Ashwagandha Root Extract on Sexual Health in Women.

NCT07182253

COMPLETED NA

Efficacy and Safety of Shatavari in Women Sexual Wellness: A Prospective, Randomized, Double-Blind, Three-arm, Parallel, Placebo-Controlled Study

NCT06972706

COMPLETED

Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults

NCT06244147

COMPLETED NA

Effects of Ashwagandha Extract (Capsule KSM-66 300 mg) on Sexual Health in Healthy Women

NCT05831241

COMPLETED NA

A Study of Sabroxy™ (Oroxylum Indicum Extract) for Improving Cognitive Function in Adults With Mild Memory Concerns

NCT07189754

What is open in the SF Research Institute pipeline

8 recruiting of 16 indexed (50% open); 6 completed (38%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Stress (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

SF Research Institute: open-pipeline peers nationwide

Peers matched on 16 registered trials and 50% open enrollment, not the therapeutic-area sidebar.

SF Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05101520 0%20%40%60% Total trials Recruiting share SF Research InstituteAccelerated Community Oncology Research NetworkAltimmuneAmerican UniversityAnthera Pharmaceuticals1200 Pharma1ST Biotherapeutics3ive Labs60 Degrees Pharmaceuticals
SF Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

SF Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 16 trials (± recruiting share)

Sponsors near 50% open enrollment (± trial volume)

What to do with this SF Research Institute page

16 registered trials is a research-attention snapshot, not an endorsement of SF Research Institute or any single study.

  • 8 of SF Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stress is the condition SF Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stress trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

SF Research Institute pipeline card: 16 registered trials from official public datasets.Report a data error.